3,4-disubstituted azetidinones as selective inhibitors of the cysteine protease cathepsin K. Exploring P3 elements for potency and selectivity

被引:29
作者
Setti, EL [1 ]
Davis, D [1 ]
Janc, JW [1 ]
Jeffery, DA [1 ]
Cheung, H [1 ]
Yu, W [1 ]
机构
[1] Celera Genom, San Francisco, CA 94080 USA
关键词
D O I
10.1016/j.bmcl.2004.12.088
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis of a series of highly potent and selective inhibitors of cathepsin K based on the 3,4-disubstituted azetidin-2-one warhead is reported. A high degree of potency and selectivity was achieved by introducing a basic nitrogen into the distal part of the P3 element of the molecule. Data from kinetic and mass spectrometry experiments are consistent with the interpretation that compounds of this series transiently acylate the sulfhydrile of cathepsin K. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1529 / 1534
页数:6
相关论文
共 25 条
  • [1] SYNTHESIS AND ANTIBACTERIAL ACTIVITY OF C4 SUBSTITUTED MONOBACTAMS
    ARNOULD, JC
    BOUTRON, P
    PASQUET, MJ
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1992, 27 (02) : 131 - 140
  • [2] L-TRANS-EPOXYSUCCINYL-LEUCYLAMIDO(4-GUANIDINO)BUTANE (E-64) AND ITS ANALOGS AS INHIBITORS OF CYSTEINE PROTEINASES INCLUDING CATHEPSINS B, H AND L
    BARRETT, AJ
    KEMBHAVI, AA
    BROWN, MA
    KIRSCHKE, H
    KNIGHT, CG
    TAMAI, M
    HANADA, K
    [J]. BIOCHEMICAL JOURNAL, 1982, 201 (01) : 189 - 198
  • [3] 4-alkylidene-azetidin-2-ones: Novel inhibitors of leukocyte elastase and gelatinase
    Cainelli, G
    Galletti, P
    Garbisa, S
    Giacomini, D
    Sartor, L
    Quintavalla, A
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (24) : 5391 - 5399
  • [4] Inactivation of cysteine proteases by (acyloxy)methyl ketones using S′-P′ interactions
    Dai, Y
    Hedstrom, L
    Abeles, RH
    [J]. BIOCHEMISTRY, 2000, 39 (21) : 6498 - 6502
  • [5] Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts
    Drake, FH
    Dodds, RA
    James, IE
    Connor, JR
    Debouck, C
    Richardson, S
    LeeRykaczewski, E
    Coleman, L
    Rieman, D
    Barthlow, R
    Hastings, G
    Gowen, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) : 12511 - 12516
  • [6] TOWARD A MOLECULAR UNDERSTANDING OF SKELETAL DEVELOPMENT
    ERLEBACHER, A
    FILVAROFF, EH
    GITELMAN, SE
    DERYNCK, R
    [J]. CELL, 1995, 80 (03) : 371 - 378
  • [7] Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L
    Falgueyret, JP
    Oballa, RM
    Okamoto, O
    Wesolowski, G
    Aubin, Y
    Rydzewski, RM
    Prasit, P
    Riendeau, D
    Rodan, SB
    Percival, MD
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (01) : 94 - 104
  • [8] GOWEN M, 1997, EXPERT OPIN INV DRUG, V6, P1999
  • [9] REVERSIBLE BINDING OF PEPTIDE ALDEHYDES TO PAPAIN - STRUCTURE-ACTIVITY-RELATIONSHIPS
    HANZLIK, RP
    JACOBER, SP
    ZYGMUNT, J
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1073 (01) : 33 - 42
  • [10] High-throughput screening of enzyme inhibitors: Automatic determination of light-binding inhibition constants
    Kuzmic, P
    Sideris, S
    Cregar, LM
    Elrod, KC
    Rice, KD
    Janc, JW
    [J]. ANALYTICAL BIOCHEMISTRY, 2000, 281 (01) : 62 - 67